	Ebitda		Date
Acadia Pharmaceuticals	USD 35.76M	447K	2025-09
Alnylam Pharmaceuticals	USD 381.78M	362.95M	2025-09
Amarin	USD 12.54M	28.57M	2025-06
BioMarin Pharmaceutical	USD 295.45M	49.49M	2025-06
DBV Technologies	USD -33.48M	5.55M	2025-09
Halozyme Therapeutics	USD 248.25M	22.74M	2025-09
Incyte	USD 581.52M	358.87M	2025-06
Insmed	USD -297.13M	71.11M	2025-06
Ionis Pharmaceuticals	USD -157.12M	307.36M	2025-09
Neurocrine Biosciences	USD 246.7M	93.8M	2025-09
PTC Therapeutics	USD -33.11M	1B	2025-06
Sarepta Therapeutics	USD 126.42M	416.82M	2025-06
Ultragenyx Pharmaceutical	USD -91.34M	35.09M	2025-06
United Therapeutics	USD 436.8M	34.2M	2025-06

DBV Technologies - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.